Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

NovaDerm and Solidaris Capital: How Selective Narratives Obscure Regulatory Evasion and Charitable Tax Misuse

Solidaris markets itself as a socially responsible investment platform promising large deductions, but public records and whistleblower reports reveal significant operational discrepancies.

International Business Times

Police smash Europe-wide synthetic drug ring in biggest bust yet

A coordinated European police operation has dismantled a vast cross-border synthetic drug ring in what investigators hailed as the largest operation of its kind to date.

Radio France Internationale

The Incentive Problem in Healthcare and Jacob Fuchs's Journey to Fix It

As a pharmacist by training and a builder by instinct, Jacob Fuchs, founder of Premier Pharma, approaches healthcare with a systems-level mindset shaped by years of hands-on experience.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

GSK to buy food allergy drug maker RAPT in $2.2bn deal

US-based biotech firm is developing treatment for allergies to nuts, milk and eggs in children and adults

The Guardian - UK

EU Mulls Tariffs and Market Restrictions on US in Response to Greenland Threat

EU considers $108B in tariffs and market restrictions on the U.S. after Trump's Greenland threats, raising trade tensions.

International Business Times

Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on drugs cleared under a new plan to slash FDA drug review times

The Independent UK

Generic Ozempic drugs are about to flood the market

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high prices

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

British Columbia ending its 3-year drug decriminalization pilot project

Canada’s Pacific coast province of British Columbia is ending its three-year experiment in decriminalizing possession of small amounts of drugs

The Independent UK

Reducing Injection Anxiety: Painless World Aims to Give Patients the Confidence to Inject at Home

From chronic disease management to fertility treatments and hormone therapies, millions of patients are now expected to administer injections at home rather than in clinical settings. The global self-injection devices market is expected to reach over $19 billion by 2030.

International Business Times

Revealed: the crypto entrepreneur linked to illegal weight-loss drug operation

Haul of illicit products led by medicines regulator was described as world’s largest of its kind, but no arrests have yet been made

The Guardian - UK

Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war

First and only GLP-1 pill on the market costs significantly less than injectable versions

The Guardian - UK

NHS Refuses to Fund Life-Saving Motor Neurone Disease Medication Despite Free Supply From Drugmaker

MND patients in the UK denied access to lifesaving drug tofersen, despite Biogen supplying it free, due to NHS covering administration costs.

International Business Times UK

US Drug Pricing Deal May Lead to Swiss Medicine Price Hikes

US drug price cuts may push up the cost of new medicines in Switzerland, Roche's CEO warns.

International Business Times

PPE company linked to ex-Tory peer Michelle Mone goes into liquidation

PPE Medpro owes government £148m for supplying unusable personal protective equipment during Covid-19 pandemic

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

PPE Medpro wound up after being ordered to pay £148m to Government

The decision could mean that the Government is unlikely to see most of the £148 million owed to it by the company.

The Guardian - UK

The UK’s pharma deal was vital – but the GSK boss is right about US dominance

It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pact

The Guardian - UK

US is the best place for drug companies to invest, says boss of London-based GSK

Emma Walmsley’s praise for US pharmaceutical market piles pressure on UK government

The Guardian - US

Texas and Florida sue FDA in latest effort to restrict abortion pill access

States’ attorneys general argue agency has failed to properly evaluate mifepristone’s safety since initial 2000 approval

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What's Going On With The Surge In Diginex Stock?

Diginex Ltd (NASDAQ:DGNX) shares are trading higher on Tuesday. The Sustainability RegTech Solutions provider posted financial results, highlighted by sharp revenue growth and a stronger balance sheet.

Benzinga

Healthcare Relevancies Clashes With Premium Valuations For Direxion's LLY-Focused ELIL, ELIS ETFs

In terms of sheer relevance, it's difficult to think of a more relevant sector than healthcare — and within this vast ecosystem, only an elite few occupy the same neighborhood as pharmaceutical giant Eli Lilly and Company (NYSE:LLY). In November 2025, Eli Lilly became the first trillion-dollar pharmaceutical company, mostly…

International Business Times

Eli Lilly, Pfizer Among 19 Drugs Approved for China's Commercial Health Insurance

China approves 19 innovative drugs for commercial health insurance, opening new market opportunities for global and local drugmakers.

The Guardian - UK

Company linked to raid on illicit weight-loss drug facility still selling unlicensed drugs

Alluvi continues sales on Telegram after MHRA seized counterfeit, unlicensed retatrutide and tirzepatide pens

Benzinga

Praxis' Epilepsy Drug Too Good To Continue, FDA Meeting Up Next

Praxis Precision Medicines Inc. (NASDAQ:PRAX) stock rose Friday after the company shared results from the registrational cohort of the EMBOLD study evaluating relutrigine for the treatment of patients with SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs).

Benzinga

Denali Flags Minimal Delay After FDA Halts Rare Disease Trial Start

The U.S. Food and Drug Administration (FDA) placed a clinical hold on Denali Therapeutics Inc.’s (NASDAQ:DNLI) investigational new drug (IND) application for the Phase 1 study of DNL952 under development for Pompe disease.

Axios

FDA reaches "tipping point" after high-level departures

Biotech and pharmaceutical companies rely on the FDA for guidance as they spend huge sums developing treatments.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.